Search results
Found 8461 matches for
An individual patient data meta-analysis of 2,017 patients from 19 studies has found a high risk of recurrence following treatment of P. vivax malaria with artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) unless they are co-administered with primaquine. The research supports recommendations that these artemisinin-based combination therapies (ACT) should be combined with primaquine.
Andrea Soult
Andrea Soult - Research Pharmacist
Thitthiphone Olinh
Thitthiphone Olinh - Research Pharmacist
Nicholas White
COVID-19 Investigators Principal Investigators Research Scientists
FRS Nicholas White - Professor of Tropical Medicine
Naomi Waithira
COVID-19 Investigators Graduate Students Research Scientists
Naomi Waithira - MORU head of Data Management